Federated Hermes Inc. Raises Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Federated Hermes Inc. grew its holdings in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 1,824.5% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 279,634 shares of the company’s stock after buying an additional 265,104 shares during the period. Federated Hermes Inc.’s holdings in [...]

featured-image

Federated Hermes Inc. grew its holdings in Doximity, Inc. ( NASDAQ:DOCS – Free Report ) by 1,824.

5% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 279,634 shares of the company’s stock after buying an additional 265,104 shares during the period. Federated Hermes Inc.



’s holdings in Doximity were worth $7,821,000 as of its most recent filing with the Securities & Exchange Commission. Other institutional investors and hedge funds have also made changes to their positions in the company. Victory Capital Management Inc.

lifted its holdings in shares of Doximity by 21.3% in the 4th quarter. Victory Capital Management Inc.

now owns 32,863 shares of the company’s stock worth $921,000 after acquiring an additional 5,780 shares during the last quarter. Jump Financial LLC bought a new stake in shares of Doximity in the 4th quarter worth about $202,000. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Doximity in the 4th quarter worth about $391,000.

Norges Bank bought a new stake in shares of Doximity in the 4th quarter worth about $35,995,000. Finally, Trexquant Investment LP lifted its holdings in shares of Doximity by 58.9% in the 4th quarter.

Trexquant Investment LP now owns 99,966 shares of the company’s stock worth $2,803,000 after acquiring an additional 37,069 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Up 1.8 % Shares of Doximity stock opened at $40.16 on Wednesday.

The firm’s 50 day moving average price is $32.66 and its 200-day moving average price is $28.84.

Doximity, Inc. has a 52-week low of $19.71 and a 52-week high of $40.

92. The company has a market cap of $7.45 billion, a P/E ratio of 55.

78, a PEG ratio of 5.15 and a beta of 1.27.

Analysts Set New Price Targets Several equities research analysts have recently issued reports on DOCS shares. Evercore ISI raised their target price on shares of Doximity from $29.00 to $34.

00 and gave the stock an “in-line” rating in a report on Friday, August 9th. JPMorgan Chase & Co. lifted their price objective on shares of Doximity from $27.

00 to $30.00 and gave the company a “neutral” rating in a report on Monday, August 19th. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $27.

00 to $19.00 in a report on Thursday, July 18th. Barclays lifted their price objective on shares of Doximity from $31.

00 to $35.00 and gave the company an “equal weight” rating in a report on Friday, August 9th. Finally, Morgan Stanley lifted their price objective on shares of Doximity from $25.

00 to $26.00 and gave the company an “underweight” rating in a report on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock.

According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $32.42. Get Our Latest Report on DOCS Insider Transactions at Doximity In other news, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction that occurred on Friday, August 9th.

The shares were sold at an average price of $35.00, for a total value of $1,050,000.00.

Following the transaction, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link . In other news, Director Watkin Phoebe L.

Yang sold 1,940 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $28.22, for a total value of $54,746.

80. Following the sale, the director now directly owns 12,269 shares of the company’s stock, valued at approximately $346,231.18.

The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . Also, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $35.

00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now owns 309,627 shares of the company’s stock, valued at $10,836,945.

The disclosure for this sale can be found here . Insiders have sold a total of 37,951 shares of company stock valued at $1,271,018 in the last 90 days. Insiders own 39.

40% of the company’s stock. Doximity Profile ( Free Report ) Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. ( NASDAQ:DOCS – Free Report ).

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter ..